1. Home
  2. PYPD vs SURG Comparison

PYPD vs SURG Comparison

Compare PYPD & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • SURG
  • Stock Information
  • Founded
  • PYPD 2008
  • SURG 2006
  • Country
  • PYPD Israel
  • SURG United States
  • Employees
  • PYPD N/A
  • SURG N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • SURG Advertising
  • Sector
  • PYPD Health Care
  • SURG Consumer Discretionary
  • Exchange
  • PYPD Nasdaq
  • SURG Nasdaq
  • Market Cap
  • PYPD 30.1M
  • SURG 27.0M
  • IPO Year
  • PYPD 2020
  • SURG N/A
  • Fundamental
  • Price
  • PYPD $2.75
  • SURG $2.25
  • Analyst Decision
  • PYPD Strong Buy
  • SURG Strong Buy
  • Analyst Count
  • PYPD 2
  • SURG 1
  • Target Price
  • PYPD $10.50
  • SURG $8.50
  • AVG Volume (30 Days)
  • PYPD 13.1K
  • SURG 4.5M
  • Earning Date
  • PYPD 05-07-2025
  • SURG 03-25-2025
  • Dividend Yield
  • PYPD N/A
  • SURG N/A
  • EPS Growth
  • PYPD N/A
  • SURG N/A
  • EPS
  • PYPD N/A
  • SURG N/A
  • Revenue
  • PYPD N/A
  • SURG $60,881,173.00
  • Revenue This Year
  • PYPD N/A
  • SURG $59.22
  • Revenue Next Year
  • PYPD N/A
  • SURG $75.86
  • P/E Ratio
  • PYPD N/A
  • SURG N/A
  • Revenue Growth
  • PYPD N/A
  • SURG N/A
  • 52 Week Low
  • PYPD $2.37
  • SURG $1.05
  • 52 Week High
  • PYPD $5.09
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 42.15
  • SURG 63.22
  • Support Level
  • PYPD $2.66
  • SURG $1.70
  • Resistance Level
  • PYPD $2.97
  • SURG $2.50
  • Average True Range (ATR)
  • PYPD 0.14
  • SURG 0.25
  • MACD
  • PYPD -0.02
  • SURG 0.09
  • Stochastic Oscillator
  • PYPD 8.86
  • SURG 50.81

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: